Symbol="CHRS"
AssetType="Common Stock"
Name="Coherus BioSciences Inc"
Description="Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California."
CIK="1512762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="481789000"
EBITDA="-234919008"
PERatio="None"
PEGRatio="0"
BookValue="-2.441"
DividendPerShare="0"
DividendYield="0"
EPS="-3.59"
RevenuePerShareTTM="2.347"
ProfitMargin="-1.48"
OperatingMarginTTM="-1.302"
ReturnOnAssetsTTM="-0.3"
ReturnOnEquityTTM="-16.57"
RevenueTTM="183363000"
GrossProfitTTM="-58399000"
DilutedEPSTTM="-3.59"
QuarterlyEarningsGrowthYOY="-0.755"
QuarterlyRevenueGrowthYOY="-0.46"
AnalystTargetPrice="13.63"
TrailingPE="-"
ForwardPE="32.89"
PriceToSalesRatioTTM="2.354"
PriceToBookRatio="73.19"
EVToRevenue="3.202"
EVToEBITDA="-3.109"
Beta="0.887"
num_52WeekHigh="14.11"
num_52WeekLow="3.6"
num_50DayMovingAverage="4.514"
num_200DayMovingAverage="6.74"
SharesOutstanding="94468000"
DividendDate="None"
ExDividendDate="None"
symbol="CHRS"
open="4.75"
high="5.25"
low="4.56"
price="5.11"
volume="7459007.00"
latest_trading_day="2023-08-03"
previous_close="4.34"
change="0.77"
change_percent="17.7419%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="2742622"
Change_recent_avg="-0.02"
Delta_recent_avg="0.4"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="-0.62"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="166"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0010.jpeg"
image_negative_thumbnail_id_2="1103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="522"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="693"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
